Page 803 - Read Online
P. 803

Page 6 of 9                                         Calabrò et al. Hepatoma Res 2020;6:69  I  http://dx.doi.org/10.20517/2394-5079.2020.63

               included the level of AST[(OR: 1.04 (1.004-1.076); P = 0.029] and presence of NASH [OR: 2.41 (1.007-5.782);
               P = 0.048].


                              [45]
               Zelber-Sagi et al. , evaluated the association between coffee consumption and hepatic steatosis onset
               in a cohort of 347 patients, comparing them with a control group. Hepatic steatosis was quantified by
               ultrasound and SteatoTest and the degree of fibrosis was assessed by FibroTest. During recruitment, a
               questionnaire relating to coffee consumption was filled. The study found that neither the incidence nor
               the prevalence of steatosis was associated with coffee consumption. Moreover, coffee consumption was
               associated with a lower clinically significant percentage of fibrosis ≥ F2 (8.8% vs. 16.3%; P = 0.038) and the
               multivariate logistic regression analysis related the high coffee consumption with a lower probability of
               fibrosis (probability ratio = 0.49, 95% confidence interval, 0.25-0.97; P = 0.041). In a retrospective study by
                         [46]
               Hodge et al. , a total of 1,018 patients (441 women, 577 men) affected by NAFLD, Hepatitis C (HCV), and
               hepatitis B (HBV) were recruited for determining the effects of coffee and tea intake on liver stiffness (SE).
               Data showed that SE was higher in males than in females (P < 0.05). HBV patients had a lower SE than
               those with HCV and NAFLD. Those who drank 2 or more cups of coffee a day had a lower SE (P = 0.044).
               Tea consumption had no effect on SE (P = 0.9). The study showed that coffee consumption reduces the SE
               with a decrease of fibrosis and inflammation.

                            [47]
               Alferink et al.  recruited 2,424 participants (age 66.5 ± 7.4; 43% male)who were asked to fill in a
               questionnaire on eating habits and lifestyle. All patients were examined by liver elastography and
               ultrasonography to evaluate liver stiffness and the degree of liver steatosis. Coffee and tea consumption
               were classified into: no intake (0), moderate (> 0-3) or frequent intake ≥ 3) (cups/day). Fibrosis was
               defined as a measure of SE. During course of the study, univariate linear and logistic regression analyzes
               were performed to examine the association between coffee, herbal /green/black tea consumption and
               SE. For the regression models, multivariable adjustments were made taking into consideration age, sex,
               BMI, insulin resistance, steatosis, serum ALT, alcohol intake, smoking, use of cream in coffee, use of
               sugar in tea or coffee and physical activity. The results showed that the SE was inversely related to a higher
               consumption of coffee (7.8%, 6.9% and 4.1% for non consumption, moderate and frequent respectively; P
               = 0.006). In general, frequent coffee consumption was inversely related to SE but not to steatosis. More in-
               depth analysis and studies are needed to validate the underlying mechanisms. The daily consumption of
               three or more cups of coffee was linked to the presence of a low SE, regardless of many other lifestyle and
               environmental factors.


               CONCLUSION
               Although the protective role of coffee in NAFLD is still controversial, several studies have shown that
               coffee consumption in patients with NAFLD can be protective against liver steatosis, progression of fibrosis
                              [48]
               and liver damage . The antioxidant capacity of coffee has been demonstrated in animal models of fatty
               liver, in which caffeine intake improves insulin resistance and reduces the production of inflammatory
               cytokines. Moreover, the weight of the animals and the intrahepatic levels of glucose were reduced with
               coffee consumption. However, not all the studies were concordant on the protective effect of coffee against
               NAFLD: controversial results may be due to the heterogeneity of the patients analyzed, the different
               protocols of research, and the different methods of collecting data. Furthermore, it should be emphasized
               that the content of caffeine and the different compounds typical of coffee can be influenced by the type of
               coffee examined, the type of roasting, the volume of water used, and the type of grinding: all these elements
               should therefore be standardized to avoid variations in the concentration of the most active compounds.


               In conclusion, the overall trend emerging from the literature review suggests that regular coffee
               consumption might be a protective factor against the evolution of NAFLD complications, especially liver
               fibrosis. Additional studies should be carried out to further characterize the correlation between coffee and
   798   799   800   801   802   803   804   805   806   807   808